mAb 216
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mAb 216, covering 2016-06-03 to 2016-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia [Phase 1]